Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tetrahydrouridine dihydrate (THU dihydrate) is a potent cytidine deaminase (CDA) inhibitor. Tetrahydrouridine dihydrate competitively blocks the active site of the enzyme more effectively than intrinsic cytidine.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | Tetrahydrouridine dihydrate (THU dihydrate) is a potent cytidine deaminase (CDA) inhibitor. Tetrahydrouridine dihydrate competitively blocks the active site of the enzyme more effectively than intrinsic cytidine. |
In vitro | Tetrahydrouridine (THU), a specific cytidine deaminase (CDA) inhibitor, effectively prevents the deamination process in the metabolism of cytotoxic deoxycytidine analogues, such as ara-C and Gemcitabine. Research involving combination therapy demonstrates that THU enhances Gemcitabine's anti-cancer efficacy against pancreatic and lung carcinoma cells. Notably, BxPC-3 and H441 cells, with high CDA expression, exhibit significantly increased sensitivity to Gemcitabine following a 100 μM THU treatment, with sensitivity augmenting by approximately 2.1 and 4.4 fold, respectively. Conversely, MIAPaCa-2 and H1299 cells, characterized by low CDA expression, also show unexpected sensitivity increases to Gemcitabine, with a 2.2 and 2.3 fold enhancement in IC 50 respectively. However, Panc-1 and H322 cells display no notable change in drug responsiveness. These findings indicate that THU is capable of sensitizing certain pancreatic and lung carcinoma cells to Gemcitabine, leading to cell death, independently of CDA expression levels, and does so by halting the S-phase of the cell cycle without inducing apoptosis [1]. |
In vivo | Administration of 167 mg/kg Tetrahydrouridine (THU) followed by 1.0 mg/kg DAC led to the death of one male and eight females. Surviving animals, scheduled for termination, were mostly asymptomatic, exhibiting no treatment-related effects on body weights, food consumption, clinical chemistry, and urinalysis when treated with up to 1.0 mg/kg DAC in combination with 167 mg/kg Tetrahydrouridine [2]. |
Molecular Weight | 284.26 |
Formula | C9H20N2O8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tetrahydrouridine dihydrate inhibitor inhibit